Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cantor Fitzgerald
US Army
Federal Trade Commission
Fuji
Boehringer Ingelheim

Generated: March 26, 2019

DrugPatentWatch Database Preview

Betamethasone dipropionate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for betamethasone dipropionate and what is the scope of betamethasone dipropionate patent protection?

Betamethasone dipropionate is the generic ingredient in eleven branded drugs marketed by Anda Repository, Fougera Pharms, Glenmark Generics, Perrigo New York, Taro, Schering, Merck Sharp Dohme, Savage Labs, Actavis Mid Atlantic, G And W Labs Inc, Pharmaderm, Teva, Teligent Pharma Inc, Alpharma Us Pharms, Fougera Pharms Inc, Hi-tech Pharmacal, Promius Pharma Llc, Leo Pharma As, Perrigo Israel, Tolmar, and Glenmark Pharms, and is included in sixty-four NDAs. There are ten patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Betamethasone dipropionate has seven patent family members in five countries.

There are sixty-six drug master file entries for betamethasone dipropionate. Twenty-two suppliers are listed for this compound.

Pharmacology for betamethasone dipropionate
Synonyms for betamethasone dipropionate
(11-beta,16-beta)-9-Chloro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
(11.beta.,16.beta.)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
(11beta,16beta)-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate
(8S,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate
(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-(propionyloxy)acetyl)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthr
[2-[(8S,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] propanoate
[2-[(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate
2-((2S,10S,11S,13S,15S,17S,1R,14R)-1-fluoro-17-hydroxy-2,13,15-trimethyl-5-oxo -14-propanoyloxytetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-14-yl)-2-o xoethyl propanoate
5593-20-4
593B204
826Y60901U
9-Fluoro-11.beta.-hydroxy-16.beta.-methyl-3,20-dioxo-17-(propionyloxy)pregna-1,4-dien-21-yl propionate #
9-Fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-fluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-di(propionate)
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate
9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione-17,21-dipropionate
9alpha-Fluoro-11beta,17alpha,21-trihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 17,21-Dipropionate
9alpha-Fluoro-16beta-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 17,21-dipropionate
AB01274713_02
AB01274713-01
AB01275498-01
AB2000220
AC1L2J44
AC1L3T2H
AKOS015969733
AKOS025312304
Alphatrex
AN-14216
API0001696
B3166
BDBM50421892
Beloderm
beta-Methasone 17,21-dipropionate
Betamethasone 17,21-dipropionate
BETAMETHASONE DIPROP
betamethasone dipropionat
Betamethasone Dipropionate (Diprolene)
Betamethasone dipropionate (JP17/USP)
Betamethasone dipropionate [USAN:BAN:JAN]
Betamethasone dipropionate [USAN:USP:JAN]
betamethasone propionate
Betamethasone-17,21-dipropionate
BRD-K58148589-001-03-6
BRN 3638108
C-22966
C28H37FO7
CAS-5593-20-4
CC-24614
CHEBI:31276
CHEMBL1200384
CIWBQSYVNNPZIQ-XYWKZLDCSA-N
component of Alphatrex (Salt/Mix)
component of Betasone (Salt/Mix)
CS-7549
D01637
Diproderm
Diprolene
Diprolene AF
Diprosis
Diprosone
Diprospan;Diprolene;Diprosone;Diprolene AF;Diprolene
DSSTox_CID_2672
DSSTox_GSID_22672
DSSTox_RID_76683
DTXSID2022672
EBD2157850
EINECS 227-005-2
en-17-yl propionate
FT-0082786
HMS2090K11
HY-13571
Jsp006667
KS-5303
LS-118474
Maxivate
MFCD00133140
MolPort-002-515-791
MolPort-039-145-111
NCGC00159360-02
NCGC00159443-01
NCGC00159443-02
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-.beta.,17,21-trihydroxy-16-.beta.-methyl-,17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-, 17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-,17,21-dipropionate
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11.beta.,16.beta.)-
Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16beta)
Psorion
Rinderon DP
Rinderon-DP (TN)
RL03443
S 3440
S-3440
s1688
SC-15701
Sch 11460
Sch-11460
SCHEMBL4566
SCHEMBL7519
Sernivo
Sernivo (TN)
ST024761
Tox21_113343
UNII-826Y60901U
ZINC4212137

US Patents and Regulatory Information for betamethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 071012-001 Feb 3, 1987 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Taro BETAMETHASONE DIPROPIONATE betamethasone dipropionate GEL, AUGMENTED;TOPICAL 076508-001 Dec 2, 2003 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Promius Pharma Llc SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for betamethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Schering DIPROLENE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019408-001 Jan 31, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Merck Sharp Dohme DIPROLENE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 018741-001 Jul 27, 1983 ➤ Try a Free Trial ➤ Try a Free Trial
Schering DIPROLENE betamethasone dipropionate CREAM, AUGMENTED;TOPICAL 019408-001 Jan 31, 1986 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Federal Trade Commission
US Army
AstraZeneca
Julphar
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.